A multicenter, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of levetiracetam versus placebo for social anxiety disorder (generalized type)

Trial Profile

A multicenter, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of levetiracetam versus placebo for social anxiety disorder (generalized type)

Completed
Phase of Trial: Phase III

Latest Information Update: 02 Feb 2010

At a glance

  • Drugs Levetiracetam (Primary)
  • Indications Social phobia
  • Focus Therapeutic Use
  • Most Recent Events

    • 02 Feb 2010 Results published in the Journal of Clinical Psychiatry.
    • 15 Dec 2009 Results were published in the Journal of Clinical Psychiatry.
    • 15 Dec 2009 Primary endpoint 'Liebowitz Social Anxiety Scale' has not been met.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top